A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome

Por um escritor misterioso
Last updated 31 março 2025
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
medRxiv - The Preprint Server for Health Sciences
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function, Journal of Translational Medicine
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
PDF) A time-resolved proteomic and prognostic map of COVID-19
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
IJMS, Free Full-Text
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Biomolecules, Free Full-Text
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Computational Immune Proteomics Approach to Target COVID-19
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A time-resolved proteomic and prognostic map of COVID-19 - ScienceDirect
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function, Journal of Translational Medicine
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19 - ScienceDirect

© 2014-2025 trend-media.tv. All rights reserved.